Cancer and cardiovascular disease: The impact of cardiac rehabilitation and cardiorespiratory fitness on survival

2021 ◽  
Vol 343 ◽  
pp. 139-145
Author(s):  
Tamara Williamson ◽  
Chelsea Moran ◽  
Daniele Chirico ◽  
Ross Arena ◽  
Cemal Ozemek ◽  
...  
Author(s):  
Kenneth Shinkichi Noguchi ◽  
Michael Pryzbek ◽  
Kevin Moncion ◽  
Angelica McQuarrie ◽  
Maureen J. MacDonald ◽  
...  

Smoking is an important risk factor for cardiovascular disease and all-cause mortality. Cardiac rehabilitation (CR) is effective for reducing the risk of recurrent cardiac events through improving cardiorespiratory fitness (CRF). Little is known about the influence of smoking on CRF throughout long-term CR. The purpose of this analysis was to compare CRF trajectories among individuals with positive and negative smoking history enrolled in long-term CR. Participants had a positive smoking history if they currently smoke or formerly smoked (Smoke+, n=55, mean age=64.9 ± 9.0 years) and had a negative history if they never smoked (Smoke–, n=34, mean age=61.4 ± 9.0 years). CRF (VO2peak) was measured at baseline and annually thereafter for 6 years. The Smoke+ group had lower CRF compared to the Smoke– group over enrollment (β=-3.29 (SE=1.40), 95% CI -6.04, -0.54, p=0.02), but there was no interaction of smoking history and enrollment (β=0.35 (SE=0.21), 95% CI -0.06, 0.77, p=0.10). Moreover, trajectories were not influenced by pack-years (β=0.01 (SE=0.01), 95% CI -0.01, 0.04, p=0.23) or time smoke-free (β=-0.002 (SE=0.01), 95% CI -0.02, 0.02, p=0.80). Although the trajectories of CRF do not appear to be affected by smoking behaviour, individuals without a history of smoking maintained higher CRF throughout enrollment. Novelty bullets: • The benefits of long-term exercise-based cardiac rehabilitation on cardiorespiratory fitness are similar between those who have smoked and those who have never smoked. • Neither the number of pack-years nor the length of time spent smoke-free influence cardiorespiratory fitness trajectories following long-term cardiac rehabilitation.


2019 ◽  
Vol 35 (10) ◽  
pp. 1359-1365 ◽  
Author(s):  
Mike Pryzbek ◽  
Maureen MacDonald ◽  
Paul Stratford ◽  
Angelica McQuarrie ◽  
Julie Richardson ◽  
...  

Author(s):  
Esmée A. Bakker ◽  
Bram M.A. van Bakel ◽  
Wim R.M. Aengevaeren ◽  
Esther P. Meindersma ◽  
Johan A. Snoek ◽  
...  

2017 ◽  
Vol 41 (S1) ◽  
pp. S10-S10
Author(s):  
M. Nordentoft ◽  
H. Speyer ◽  
H.C.B. Norgaard ◽  
M. Birk ◽  
O. Mors

Life expectancy in patients with schizophrenia is reduced by 20 years for men and 15 years for women compared to the general population. About 60% of the excess mortality is due to physical illnesses, with cardiovascular disease being dominant. The aim of this trial was to improve the cardiovascular risk profile.MethodsThe CHANGE trial was an investigator-initiated, randomised, parallel-group, superiority, multi-centre trial with blinded outcome assessment. Patients diagnosed with schizophrenia spectrum disorders and increased waist circumference according (>88 cm for women, >102 cm for men), were recruited and centrally randomised 1:1:1 to 12-months of lifestyle coaching plus care coordination versus care coordination alone versus treatment as usual. The primary outcome was 10-year risk of cardiovascular disease assessed post-treatment and standardised to age 60, secondary outcomes included cardiorespiratory fitness and physical activity. Clinical.Trials.gov NCT01585493.FindingsA total of 428 participants were randomly assigned to the CHANGE intervention (n = 138); care coordination (n = 142); or treatment as usual (n = 148). At 12 months, the mean 10 years risk of cardiovascular disease was 8.4% (SD 6.7) in the CHANGE group, 8.5% (SD 7.5) in the care coordination group and 8.0% (SD 6.5) in the treatment as usual group (P = 0.41). We found no intervention effects for any secondary or explorative outcomes, including weight, cardiorespiratory fitness, physical activity, diet or smoking.InterpretationThe CHANGE trial did not support individual lifestyle coaching or care coordination as superior compared with treatment as usual in reducing the cardiovascular risk in patients with schizophrenia and increased waist circumference.Disclosure of interestThe authors have not supplied their declaration of competing interest.


PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0255472
Author(s):  
Prisca Eser ◽  
Thimo Marcin ◽  
Eva Prescott ◽  
Leonie F. Prins ◽  
Evelien Kolkman ◽  
...  

Introduction Studies on effectiveness of cardiac rehabilitation (CR) in elderly cardiovascular disease patients are rare, and it is unknown, which patients benefit most. We aimed to identify predictors for 1-year outcomes of cardiorespiratory fitness and CV risk factor (CVRF) control in patients after completing CR programs offered across seven European countries. Methods Cardiovascular disease patients with minimal age 65 years who participated in comprehensive CR were included in this observational study. Peak oxygen uptake (VO2), body mass index (BMI), resting systolic blood pressure (BPsys), and low-density lipoprotein-cholesterol (LDL-C) were assessed before CR (T0), at termination of CR (T1), and 12 months after start of CR (T2). Predictors for changes were identified by multivariate regression models. Results Data was available from 1241 out of 1633 EU-CaRE patients. The strongest predictor for improvement in peak VO2 was open chest surgery, with a nearly four-fold increase in surgery compared to non-surgery patients. In patients after surgery, age, female sex, physical inactivity and time from index event to T0 were negative predictors for improvement in peak VO2. In patients without surgery, previous acute coronary syndrome and higher exercise capacity at T0 were the only negative predictors. Neither number of attended training sessions nor duration of CR were significantly associated with change in peak VO2. Non-surgery patients were more likely to achieve risk factor targets (BPsys, LDL-C, BMI) than surgery patients. Conclusions In a previously understudied population of elderly CR patients, time between index event and start of CR in surgery and disease severity in non-surgery patients were the most important predictors for long-term improvement of peak VO2. Non-surgery patients had better CVRF control.


2021 ◽  
Vol 2 (1) ◽  
pp. 543-549
Author(s):  
Mike Pryzbek ◽  
Maureen MacDonald ◽  
Paul Stratford ◽  
Julie Richardson ◽  
Angelica McQuarrie ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document